文稿:平民
翻译:Darren
编辑:申睿霖
卫生部长安德鲁·利特尔（Andrew Little）今天宣布，对新西兰人一些最大的健康问题（包括癌症、糖尿病和心脏病）的研究，在最近一轮健康研究资金中得到了至关重要的支持。
这笔资金通过新西兰卫生研究理事会提供，包括31项一般项目赠款（3 664万纽币）、5项兰加豪豪拉毛利赠款（591万纽币）、5项太平洋项目赠款（579万纽币）和4项方案赠款（1 999万纽币）。
安德鲁·利特尔说：”政府致力于改善所有新西兰人的健康和福祉，研究是该计划的重要组成部分。这项重大投资有可能大大改善新西兰人的健康”。
安德鲁·利特尔说：”这项研究将调查从疫苗犹豫到改善奥塔里亚地区塔马里基基因诊断等一系列问题。
成功的应用包括毛利人和太平洋研究人员领导的项目，以及由毛利人和太平洋研究方法推动的项目，这些方法将有助于减少毛利人和太平洋人民在健康上的不平等。
在今天的公告中获得资助的研究人员之一是杰森·古尼博士（Ngöpuhi），他持有人权理事会毛利人健康研究新兴领袖奖学金。他获得了近80万纽币的奖金，以探讨糖尿病和癌症共发的日益严重的危机及其对癌症患者的影响。惠灵顿奥塔哥大学的流行病学家和高级研究员希望改善毛利人和太平洋人患疾病的数量和生活质量。
这个为期两年的研究项目是C3研究小组和怀卡托大学罗斯·劳伦森教授的研究小组合作开展的。它将探讨毛利人和帕西菲卡人中糖尿病和癌症发病率的迅速上升，以及它的影响越来越普遍，一个人有这两种情况。
正如我今年早些时候宣布对卫生系统进行重大改革时所说，毛利人和太平洋人民死于本来可以治疗的疾病的可能性是前人的两倍，毛利人或太平洋人甚至决定你得到什么样的治疗。我们处理这个问题的计划包括研究为什么会这样，并找到有效的方法来处理它。古尼博士的研究将有所帮助，也将使我们能够预测未来有多少人可能同时患上这两种疾病，以便我们能够对此进行规划”。
卫生部长说：”今年资助的项目表明，新西兰正在开发创新方法，这些方法将对卫生系统产生立竿见影的影响，而且新西兰拥有灵活而有能力的研究部门，能够应对社区需求和新兴的健康威胁。
新西兰卫生研究理事会（人权理事会）负责管理政府对卫生研究的投资。人权理事会每年通过每年一次的可竞争的筹资回合为项目、太平洋项目和方案提供资金，为每项成功的提案提供约120万纽币和高达500万纽币的赠款。资助的项目和方案具有战略性的长期愿景，将作出设想。显著改善新西兰人的健康结果。
今年的项目，要突出几点:
。 将探索卫生系统如何更好地支持和实现健康公平。
。 衡量为什么一些新西兰人拒绝或推迟接种疫苗。
。 帮助提高我年轻人感染高传染性疾病麻疹的免疫力。
。 重点是更公平地为毛利人提供肺癌筛查的机会，和评估帮助人们戒烟的方法”。
新西兰卫生研究理事会每年投资约1.2亿美元用于改善新西兰卫生系统的质量、成本效益和可持续性的研究，并有助于预防疾病和过上好的生活。Government backs critical health research
Research into some of New Zealanders’ biggest health concerns including cancer, diabetes, and heart disease is getting crucial support in the latest round of health research funding, Health Minister Andrew Little announced today.
The funding, awarded through the Health Research Council of New Zealand, covers 31 General Project grants ($36.64 million), five Rangahau Hauora Māori grants ($5.91 million), five Pacific Project grants ($5.79 million), and four Programme grants ($19.99 million).
“The Government is committed to improving the health and wellbeing of all New Zealanders, and research is a vital part of the plan,” Andrew Little said.
“This significant investment has the potential to vastly improve the health of New Zealanders.
“The research will investigate issues ranging from vaccine hesitancy through to improving genetic diagnoses for tamariki across Aotearoa,” Andrew Little said.
Included among the successful applications are projects led by Māori and Pacific researchers and driven by Kaupapa Māori and Pacific research methodologies that will help to reduce inequities in health for Māori and Pacific peoples.
One of the researchers receiving a grant in today’s announcement is Dr Jason Gurney (Ngāpuhi) who holds an HRC Māori Health Research Emerging Leader Fellowship. He is being awarded nearly $800,000 to explore the growing crisis of diabetes and cancer co-occurrence and its impact on what happens to people with cancer.
The epidemiologist and senior research fellow at the University of Otago in Wellington want to improve the quantity and quality of life for Māori and Pacific peoples who develop the diseases.
The two-year research project is a collaboration between the C3 Research Group and Professor Ross Lawrenson’s research group at the University of Waikato. It will explore the rapidly increasing rates of diabetes and cancer within Māori and Pasifika populations, and the impact of it becoming increasingly common for one person to have both conditions.
“As I said earlier this year when I announced a major reform of the health system, Māori and Pacific’s peoples are twice as likely to die young from conditions that could have been treated, and being Māori or Pacific even determines what sort of treatment you get.
“Our plan for dealing with this includes looking at why that is happening and finding effective ways to deal with it. Dr Gurney’s research will help, and will also allow us to predict how many people are likely to have both diseases in future so we can plan for that.
“The projects funded this year show New Zealand developing innovative approaches that will have an immediate effect on the health system, and that it has an agile and capable research sector that can respond to community needs and emerging health threats,” Andrew Little said.
The Health Research Council of New Zealand (HRC) is responsible for managing the Government’s investment in health research.
Each year the HRC offers funding for Projects, Pacific Projects and Programmes through an annual contestable funding round, awarding grants of approximately $1.2 million and up to $5 million for each successful proposal. Funded projects and programmes have a strategic, long-term vision that will contri. bute to significantly improving health outcomes for New Zealanders.
This year’s projects, to highlight a few, will: explore how the health system can better support and achieve health equity; gauge why some New Zealanders are refusing or delaying vaccinations; help boost immunity to the highly contagious disease measles in young adults; focus on more equitable access for lung cancer screening for Māori, and assess methods to help people quit smoking.
The Health Research Council of New Zealand invests around $120 million a year in research that improves the quality, cost-effectiveness and sustainability of New Zealand’s health system, and contributes to disease prevention and living well.
备注和负责声明
未经书面许可，保留所有权利，不得使用任何部分或完整的文章或照片。本号转载的文章都已注明出处，如对版权有任何疑问，请在第一时间发送邮件给本号， bbcc1223@126.com我们将在收到后第一时间进行删除。
若喜欢作品的可以点击“在看”，这样有机会分享给更多朋友。要是再点击“喜欢作品”，那将对我们鼓舞更大。
本号致力于好文推送，并对文中观点保持中立，所发内容仅供学习、交流。版权归原作者或机构所有，部分文章推送时未能查实原作者，在这里对你们表示深深的敬意。若涉及版权问题，麻烦请留言联系删除